Multimodality therapy in subclassified stage IIIA–N2 non-small cell lung cancer patients according to the Robinson classification: heterogeneity and management
Hofmann, Hans-Stefan, Braess, Jan, Leipelt, Susanne, Allgäuer, Michael, Klinkhammer-Schalke, Monika, Szoeke, Tamas, Grosser, Christian, Pfeifer, Michael and Ried, Michael (2018) Multimodality therapy in subclassified stage IIIA–N2 non-small cell lung cancer patients according to the Robinson classification: heterogeneity and management. Journal of Thoracic Disease 10 (6), pp. 3585-3594.Date of publication of this fulltext: 28 Jul 2021 17:15
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Thoracic Disease | ||||
| Publisher: | AME PUBL CO | ||||
|---|---|---|---|---|---|
| Place of Publication: | SHATIN | ||||
| Volume: | 10 | ||||
| Number of Issue or Book Chapter: | 6 | ||||
| Page Range: | pp. 3585-3594 | ||||
| Date | 2018 | ||||
| Institutions | Medicine > Abteilung für Thoraxchirurgie | ||||
| Identification Number |
| ||||
| Keywords | RANDOMIZED CONTROLLED-TRIAL; PREOPERATIVE CHEMOTHERAPY; INDUCTION CHEMOTHERAPY; TRIMODALITY THERAPY; COMPLETE RESECTION; PN2 DISEASE; PHASE-III; N2; RADIOTHERAPY; SURVIVAL; Non-small cell lung cancer (NSCLC); mediastinal lymph node; Robinson classification; tumour board; surgery; survival | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 47128 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric